Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douangsone D Vadysirisack

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Gene Therapy|January 20, 2004
Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomographyDerek K Marsee, Daniel H Y Shen, Lawrence R MacDonald, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapyDerek K Marsee, Douangsone D Vadysirisack, Carl D Morrison, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2022
Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia GravisAbeer H Obaid, Chryssa Zografou, Douangsone D Vadysirisack, et al.
Nature Communications|April 29, 2015
A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacityShuxi Qiao, Michael Dennis, Xiufeng Song, et al.
Frontiers in Immunology|August 25, 2023
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Frontiers in Immunology|October 11, 2023
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Cell|February 10, 2010
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alphaLei Zhong, Agustina D'Urso, Debra Toiber, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Gene Therapy|January 20, 2004
Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomographyDerek K Marsee, Daniel H Y Shen, Lawrence R MacDonald, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapyDerek K Marsee, Douangsone D Vadysirisack, Carl D Morrison, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2022
Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia GravisAbeer H Obaid, Chryssa Zografou, Douangsone D Vadysirisack, et al.
Nature Communications|April 29, 2015
A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacityShuxi Qiao, Michael Dennis, Xiufeng Song, et al.
Frontiers in Immunology|August 25, 2023
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Frontiers in Immunology|October 11, 2023
Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activationGuo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, et al.
Cell|February 10, 2010
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alphaLei Zhong, Agustina D'Urso, Debra Toiber, et al.
Pageof 2